Coiled Therapeutics Commences Trading on AIM After Raising £8.5 Million
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowCoiled Therapeutics has officially started trading on the AIM market following a successful capital raise of £8.5 million. This funding aims to support the company's ongoing research and development initiatives. The initiation of trading marks a significant step for Coiled Therapeutics, which could impact investor perception in the biotech sector. Such fundraising events often influence stock liquidity and market participation.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
